Results 61 to 70 of about 29,392 (188)

Accidental apixaban intoxication in a 23-month-old child: a case report

BMC Pediatrics, 2020
Background Direct oral anticoagulants, such as apixaban, are increasingly used in everyday practice in order to treat or prevent thromboembolic diseases. To date, there is no available data about apixaban pharmacokinetics in children, and no intoxication
Manon Launay, Yara Nasser, Isabelle Maubert, Anne-Cécile Chaux, Xavier Delavenne   +4 more
doaj   +1 more source

Conducting clinical lactation trials in the United Kingdom—Reflections from the New Horizons clinical trial

British Journal of Clinical Pharmacology, EarlyView.
Jignesh P. Patel, Roopen Arya
wiley   +1 more source

Variation in Anticoagulation Practice for Atrial High‐Rate Episodes: A Nationwide Cross‐Sectional Survey

Journal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Atrial high‐rate episodes (AHRE) detected by cardiac implantable electronic devices (CIEDs) are associated with increased thromboembolic risk, yet their clinical significance and optimal anticoagulation strategy remain uncertain, particularly in the absence of electrocardiogram (ECG)‐confirmed atrial fibrillation.
Kyi Zin Thant, Ibrahim Antoun, Kaung Myat Thu, Riyaz Somani, Zakariyya Vali, G. Andre Ng, Mokhtar Ibrahim   +6 more
wiley   +1 more source

Tornado diagram of apixaban versus warfarin.

, 2016
Tornado diagram of apixaban versus warfarin.
Ian C. K. Wong (306894), Wallis C. Y. Lau (3161145), Gregory Y. H. Lip (195779), Vicki C. Tse (3161148), Esther W. Chan (607486), Xue Li (285380), Bernard M. Y. Cheung (317332)   +6 more
core   +1 more source

The DOAC‐FRAIL Study—Same Dose, Different Story: Prevalence of Deviant Direct Oral Anticoagulant Levels in Nursing Home Residents

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Direct oral anticoagulants (DOACs) are prescribed using fixed dosing regimens, despite limited evidence on their pharmacokinetic behavior in nursing home residents. Participants and Setting One hundred nursing home residents are receiving apixaban, rivaroxaban, dabigatran, or edoxaban in multiple long‐term care facilities in the ...
Irme S. Franssen, Melanie J. de Jong, Lars Visseren, Daan Teerds, Dave Hellenbrand, Yvonne Henskens, Henri Spronk, Daisy J. A. Janssen, Dionne C. W. Braeken, Sander M. J. van Kuijk, Kristien Winckers, Fabienne J. H. Magdelijns   +11 more
wiley   +1 more source

Quick reference guide to apixaban [Corrigendum]

, 2017
Hurst KV, O’Callaghan JM, Handa A. Vascular Health and Risk Management. 2017:13 263–267.On page 264, Table 2 states that the apixaban dose should be reduced in patients with mild hepatic impairment and that it is not indicated in patients ...
Handa A, O'Callaghan JM, Hurst KV
core  

Apixaban plasma level and anti-FXa activity in control and apixaban with amiodarone groups.

Apixaban plasma level and anti-FXa activity in control and apixaban with amiodarone groups.
Weerayuth Saelim (17817282), Wichai Santimaleeworagun (8679282), Pornwalai Boonmuang (17817273), Sutee Limcharoen (17817270), Manat Pongchaidecha (17817276), Sarawuth Limprasert (8931053), Juthathip Suphanklang (17817279), Piyarat Pimsi (17817285)   +7 more
core   +1 more source

Sleep characteristics and self‐reported sleep quality in the oldest‐old: Results from a prospective longitudinal cohort study

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Little is known about the correlation between subjective perception and objective measures of sleep quality in particular in the oldest‐old. The aim of this study was to perform longitudinal home sleep monitoring in this age group, and to correlate results with self‐reported sleep quality.
Hugo Saner, Kevin Möri, Narayan Schütz, Philipp Buluschek, Tobias Nef   +4 more
wiley   +1 more source

Direct oral anticoagulant and AKI: apixaban-induced acute interstitial nephritis.

, 2019
Direct oral anticoagulants (DOACs)-dabigatran, rivaroxaban, apixaban and edoxaban-are changing the landscape of clinical practice for patients requiring short and long-term anticoagulation. We report a patient with no history of kidney disease developing
Hanna, Wael, MD, Murone, Julie, DiMaria, Christina, Reichart, James, MD   +3 more
core   +1 more source

Development of Pacemaker Lead Thrombosis in a Patient with Atrial Fibrillation during Apixaban Treatment

Journal of Tehran University Heart Center, 2019
Apixaban was introduced in clinical use for nonvalvular atrial fibrillation as an alternative to warfarin. There is a dearth of information regarding apixaban use in patients suffering from atrial fibrillation with intracardiac foreign bodies such as ...
Adem Adar, Orhan Önalan, Fahri Cakan
doaj   +1 more source